Acumen Pharmaceuticals, Inc.

Ownership Transactions Reported by 18 Insiders

Symbol
ABOS on Nasdaq
Industry
Biological Products, (No Diagnostic Substances)
Location
427 Park St., Charlottesville, VA

Insiders trading volume in the past year

Acumen Pharmaceuticals, Inc. executives and other stock owners filed with the SEC include:

Name Relationship Holdings Value Past Year Net Change Change % Report Date
Ra Capital Management, L.P. Director, 10%+ Owner $45.3M Jun 10, 2024
Sands Capital Ventures Discovery Fund III, L.P. 10%+ Owner $11.9M Jul 6, 2021
Paul B. Manning 10%+ Owner $2.28M Jul 6, 2021
Robert D. Hardie 10%+ Owner $2.28M Jul 6, 2021
Daniel Joseph OConnell President and CEO, Director $1.74M -$52.8K -2.94% Jan 19, 2024
Matt Zuga CFO & Chief Business Officer $734K -$15.7K -2.1% Jan 18, 2024
Eric Siemers Chief Medical Officer $408K -$11.6K -2.77% Jan 18, 2024
Derek Meisner Chief Legal Officer & Corp Sec $378K -$31K -7.59% Jan 19, 2024
Russell Barton Chief Operating Officer $336K -$10.6K -3.04% Jan 18, 2024
Laura Stoppel Director Jun 10, 2024
Amy Schacterle Chief Regulatory Officer Nov 5, 2024
Jeffrey L. Ives Director Jun 10, 2024
Nathan B. Fountain Director Jun 10, 2024
Derrell Porter Director Jun 10, 2024
Kimberlee C. Drapkin Director Jun 10, 2024
Jeffrey Sevigny Director Jun 15, 2022
John A. Stalfort III Director Jun 10, 2024
James J. Doherty President and CDO Feb 1, 2024

Recent Insider Transactions by Companies or Individuals for Acumen Pharmaceuticals, Inc.

Insider Symbol Class Transaction % Value $ * Price $ Shares Shares Owned Date Ownership
* An asterisk sign (*) next to the price indicates that the price is likely invalid.